Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a ...

China has stunned the global medical community with a revolutionary cure for Type 2 diabetes, offering hope to millions ...

The CL1 is the first commercial system from the same researchers who wowed the tech world in 2022 by teaching a cluster of ...

Pasca Lab specializes in growing three-dimensional organoid models from reprogrammed stem cells, which capture molecular changes during fetal brain-like development. Because the human brain cannot be ...

Stem-cell–based therapies aim to change that paradigm by repairing or replacing damaged biological systems. If replicated successfully in larger patient populations, the approach could reduce ...

In a major medical breakthrough, researchers in China have successfully used stem cell therapy to reverse both type 1 and ...

Three emerging Māori researchers leading innovative projects to improve cancer outcomes for whānau Māori will receive this ...

After treatment, the mice’s memories were essentially shunted back into a younger state. The researchers found that reprogrammed engrams displayed molecular behavior of more youthful cells. Using a ...

Most vaccines work like a “wanted” poster. They show the immune system a specific feature of a microbe so it can recognize ...